Cordellini S, Sannomiya P
Department of Pharmacology, Institute of Biosciences, University Estadual Paulista, Botucatu, São Paulo, Brasil.
Gen Pharmacol. 1999 Mar;32(3):393-400. doi: 10.1016/s0306-3623(98)00222-5.
The objective was to estimate alterations in adrenergic receptor sites of guinea pig vas deferens, in vivo and in vitro, induced by chronic denervation. The denervation process induced an increased sensitivity (3-fold at the EC50 level) without alteration in the maximum response to phenylephrine in vitro. The sensitivity alteration was characterized by the decrease in the dissociation constant of phenylephrine for alpha-adrenoceptor [K(A): normal tissue 3.50 (0.75-16.21) x 10(-5) and denervated tissue 0.43 (0.11-1.67) x 10(-5) M, p < 0.05] without changing the dissociation constant of prazosin. A decrease in pD'2 value for phenylephrine-phenoxybenzamine, probably due to a qualitative rather than a quantitative alteration in the alpha-adrenoceptor, was also shown in vitro [pD'2: normal tissue (8.2776+/-0.0402) and denervated tissue (8.0051+/-0.0442), p < 0.05]. No change in sensitivity and maximum response to phenylephrine was observed in vivo after denervation, although an increased resistance of vas deferens to phenoxybenzamine blockade has been evidenced in this condition.
目的是评估慢性去神经支配在体内和体外诱导的豚鼠输精管肾上腺素能受体位点的变化。去神经支配过程在体外诱导了敏感性增加(在EC50水平增加3倍),但对去氧肾上腺素的最大反应没有改变。敏感性变化的特征是去氧肾上腺素对α-肾上腺素能受体的解离常数降低[K(A):正常组织为3.50(0.75 - 16.21)×10(-5),去神经组织为0.43(0.11 - 1.67)×10(-5) M,p < 0.05],而哌唑嗪的解离常数没有变化。体外实验还显示,去氧肾上腺素 - 酚苄明的pD'2值降低,这可能是由于α-肾上腺素能受体的定性而非定量改变所致[pD'2:正常组织为(8.2776 ± 0.0402),去神经组织为(8.0051 ± 0.0442),p < 0.05]。去神经支配后在体内未观察到对去氧肾上腺素的敏感性和最大反应发生变化,尽管在这种情况下已证明输精管对酚苄明阻断的抵抗力增加。